SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Fugh-Berman A. The corporate coauthor. J Gen Intern Med. 2005;20: 5468.
  • 2
    Rubin R. Medical editors: one-sided drug reviews hard to swallow. USA Today. May 30, 2005. Available at: http://www.usatoday.com/news/health/2005-05-30-drug-reviews_x.htm. Cited July 31, 2005.
  • 3
    Wilkes MS, Doblin BH, Shapiro MF. Pharmaceutical advertisements in leading medical journals: experts' assessments. Ann Intern Med. 1992;116: 9129.
  • 4
    Tsai AC. Conflicts between commercial and scientific interests in pharmaceutical advertising in medical journals. Int J Health Serv. 2003;33: 75168.
  • 5
    Winslow R, Zimmerman R. High blood pressure: doctors sever ties with medical journal. Wall Street Journal. July 29, 2005: B1.
  • 6
    Carrasquillo O, Goodman RL. Should Astra-Zeneca give us a free lunch. Society of General Internal Medicine Forum. March 2001.
  • 7
    Society of General Internal Medicine. Policy on acceptance and disclosure of external funds. Available at http://www.sgim.org/PolicyExternalFund.cfm. Cited July 31, 2005.
  • 8
    The National Medical Association Launched the W. Montague Cobb/NMA Health Policy Institute to Address Health Disparities. National Medical Association Press Release, December 10, 2004. Available at http://www.nmanet.org/pr_121004.htm. Cited July 31, 2005.